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hTATE-OF-THE-ART PAPER747Left Ventricular Endocardial Pacingierre Bordachar, Nicolas Derval, Sylvain Ploux, Stephane Garrigue, Philippe Ritter,
ichel Haissaguerre, Pierre Jais
ordachar and colleagues review the risks and challenges associated with endocardially placing
left ventricular lead in patients who cannot have a lead placed into an appropriate coronary
ein. Theoretically, endocardial placement has several advantages, including the ability to
lace the lead at the site with the most favorable hemodynamic benefit regardless of the
natomy of the coronary venous system and more physiologic endocardial-to-epicardial
epolarization. The risks include thromboembolic complications and damage to the mitral
alve for leads placed transseptally. The adoption of endocardial stimulation will require
eveloping safe and durable instrumentation and intraprocedural methods to identify the
ptimal site of stimulation.IEWPOINT754Expanding the Indications for CRTutger J. Van Bommel, Victoria Delgado, Martin J. Schalij, Jeroen J. Bax
ardiac resynchronization therapy (CRT) is an effective treatment for patients with drug-
efractory, chronic heart failure. Based on the results of clinical trials, current guidelines
onsider CRT a Class I indication for heart failure patients in New York Heart Association
NYHA) functional class III to IV, with depressed left ventricular ejection fraction 35%,
nd with a QRS complex 120 ms. Recent trials have suggested that some patients who do
ot fulfill these criteria may also benefit from CRT. Van Bommel and colleagues review these
rials and discuss the role of CRT in patients in NYHA functional class I to II or with a
ormal QRS complex.OMMENTARY763CRT Use Should Be Restricted to the Current Guidelineshomas H. Marwick, Richard A. Grimm
n a commentary responding to the viewpoint paper by Van Bommel and colleagues,
arwick and Grimm argue that the current guidelines restricting the use of cardiac
esynchronization therapy (CRT) implantation should not be expanded. They note that
linical practice has drifted away from the evidence base from clinical trials, involving patients
ho are older and with more comorbidities, with 10% having ejection fraction 35% and 6%
aving an ejection fraction 40%. They are also more skeptical of clinical trials advocatingthe expansion of CRT.(continued on page A-19)
CAUGUST 31, 2010 (continued) A-19A
M
F
C
r
“

Q
o
o
m
m
C
D
C
S
p
t
w
e
I
a
t
s
E
A
M
J
P
A
c
t
m
i
l
pARDIAC RESYNCHRONIZATION766One-Quarter of CRT Device Implants Do Not Meet Established Criteriadam S. Fein, Yongfei Wang, Jeptha P. Curtis, Frederick A. Masoudi, Paul D. Varosy,
atthew R. Reynolds, on behalf of the National Cardiovascular Data Registry
ein and colleagues used data from the National Cardiovascular Data Registry’s Implantable
ardiac-Defibrillator Registry to determine what percentage of patients undergoing cardiac
esynchronization therapy (CRT) device implantation do not meet consensus guidelines.
Off-label” implants were defined as those for patients in whom the ejection fraction was
35%, the New York Heart Association (NYHA) functional class was below III, or the
RS duration was 120 ms in the absence of a documented need for ventricular pacing. In
ver 45,000 implants, 24% of devices were placed without meeting all 3 implant criteria, most
ften due to NYHA functional class below III (13.1% of implants) or QRS duration 120
s (12.0%). These data indicate that nearly 1 in 4 patients receiving CRT devices do not
eet guideline-based indications.ARDIAC RESYNCHRONIZATION774Endocardial Mapping Can Identify Optimal Location for LV PacingNSR VDD-RVA pacing
VDD-BiV
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Patient 11avid D. Spragg, Jun Dong, Barry J. Fetics, Robert Helm, Joseph E. Marine, Alan Cheng,
harles A. Henrikson, David A. Kass, Ronald D. Berger
pragg and colleagues postulated that endocardial biventricular (BiV) stimulation would
rovide more flexibility in left ventricular (LV) site selection and yield more natural
ransmural activation patterns. The peak rate of left ventricular pressure rise (dP/dtmax)
as measured during BiV pacing at the right ventricular apex (RVA) and various LV
ndocardial sites. Endocardial BiV improved dP/dtmax over RVA pacing in all patients.
n patients with pre-existing cardiac resynchronization therapy (CRT) leads, LV endocardial
nd epicardial pacing at the same site yielded equivalent dP/dtmax values, but other sites in
he LV often produced higher dP/dtmax values. CRT delivered at the best LV endocardial
ites is more effective than via the typical location in the mid-LV free wall.ditorial Comment: Nicolas Derval, Pierre Jaïs, p. 782TRIAL FIBRILLATION784Pericardial Fat May Predispose to AF. Obadah Al Chekakie, Christine C. Welles, Raymond Metoyer, Ahmed Ibrahim, Adam R. Shapira,
oseph Cytron, Peter Santucci, David J. Wilber, Joseph G. Akar
ericardial fat is a visceral adipose depot that possesses significant inflammatory properties.
trial fibrillation (AF) is associated with inflammation and obesity. Al Chekakie and
olleagues investigated the relationship between AF and pericardial fat using computed
omography scans to quantify the pericardial fat volume. Patients with AF had significantly
ore pericardial fat compared with patients in sinus rhythm. This association was
ndependent of age, hypertension, sex, left atrial enlargement, valvular heart disease,
eft ventricular ejection fraction, diabetes, and body mass index. Pericardial fat may
redispose to AF independent of traditional risk factors.(continued on page A-20)
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rTRIAL FIBRILLATION789Elevated CRP Is Associated With Increased Risk of AF, But Probably Not Causativearah C. W. Marott, Børge G. Nordestgaard, Jeppe Zacho, Jens Friberg, Gorm B. Jensen,
nne Tybjærg-Hansen, Marianne Benn
arott and colleagues investigated the relationship between atrial fibrillation (AF) and
-reactive protein (CRP) in over 46,000 subjects with over 2,000 cases of AF. Individuals
ere genotyped for 4 CRP gene polymorphisms, and their high-sensitivity CRP levels were
easured. A CRP level in the upper versus lower quintile was associated with a 2.2-fold
ncreased risk of AF, which attenuated slightly after multifactorial adjustment. Genotype
ombinations of the 4 CRP polymorphisms were associated with up to a 63% increase in
lasma CRP levels, but not with increased risk of AF. These findings suggest that elevated
lasma CRP does not directly increase the risk of AF but is rather a biomarker of the risk.UPRAVENTRICULAR TACHYCARDIAS796Characterization of AT Arising From the Noncoronary Aortic Sinusingpeng Liu, Jianzeng Dong, Siew Yen Ho, Ashok Shah, Deyong Long, Ronghui Yu, Ribo Tang,
eleze Hocini, Michel Haissaguerre, Changsheng Ma
iu and colleagues used 3-dimensional electroanatomical mapping, computed tomography
maging, and excised hearts to characterize atrial tachycardia (AT) arising adjacent to the
oncoronary aortic sinus (NCAS-AT). During NCAS-AT, the para-Hisian area of the
ight atrium and the anteroseptal region of the left atrium (LA) were activated almost
imultaneously. In reference patients, NCAS pacing reproduced the bi-atrial activation
attern of NCAS-AT. Anatomically, the wall of the NCAS did not contain myocardial
issue but was intimately related to the paraseptal regions of the atria. NCAS-AT has
istinct atrial activation patterns, which can be partly explained by its anatomical
elationship with the atria.(continued on page A-22)
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hUPRAVENTRICULAR TACHYCARDIAS805Calcium Clock Underlies AVJ Rate Acceleration During Sympathetic Stimulationaehyeok Kim, Tetsuji Shinohara, Boyoung Joung, Mitsunori Maruyama, Eue-Keun Choi,
oung Keun On, Seongwook Han, Michael C. Fishbein, Shien-Fong Lin, Peng-Sheng Chen
im and colleagues studied the importance of rhythmic spontaneous sarcoplasmic reticulum
alcium (Ca) release (the “Ca clock”) in atrioventricular junction (AVJ) automaticity. The
ransmembrane potential and intracellular Ca were measured in Langendorff-perfused canine
VJ preparations. The wavefront from the leading pacemaker site propagated first through
he slow pathway, then the fast pathway, and then the atria. There was no late diastolic Ca
levation at baseline, but it developed with isoproterenol infusion. Ryanodine markedly slowed
he rate of spontaneous AVJ rhythm and prevented the acceleration with isoproterenol. These
esults confirm that the Ca clock mediates AVJ rate acceleration during sympathetic
timulation.CATHETER AORTIC
VALVE IMPLANTATIONATHETER AORTIC VALVE IMPLANTATION813Case Series: Transapical Aortic Valve Implantation in 175 Patientsiralem Pasic, Axel Unbehaun, Stephan Dreysse, Thorsten Drews, Semih Buz, Marian Kukucka,
lexander Mladenow, Tom Gromann, Roland Hetzer
asic and colleagues developed a transapical aortic valve implantation (TAVI) program in
008 and herein describe their outcomes in the first 175 patients. The patients’ mean age was
0 years, with a mean Society of Thoracic Surgeons score of 23%, including 10 patients in
ardiogenic shock. Technical success of the procedure was 100%, and there was no conversion
o conventional surgery. The 30-day mortality was 3.6% for all patients without cardiogenic
hock and 30% for the patients with cardiogenic shock. Survival at 1, 6, and 12 months was
5%, 86%, and 83%, respectively. TAVI has become the primary choice of treatment for
igh-risk patients with severe aortic valve stenosis at this institution.
